Skip to main content
. 2014 Jul 28;26(3):735–745. doi: 10.1681/ASN.2014030228

Figure 3.

Figure 3.

Death-censored graft survival curve in 10-years follow-up, and pretransplant levels of IgA aB2GPI antibodies in patients with allograft failure. (A) Graft survival (DCGS) in the follow-up was significantly lower in patients in group 1. (B) Pretransplant mean levels of IgA aB2GPI in patients who had early allograft failure (graft loss or DGF) were higher than in patients without these events.